Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.
D000230:Adenocarcinoma / Q000097:blood* / Q000453:epidemiology / Q000473:pathology; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D001707:Biopsy, Needle; D018450:Disease Progression; D042241:Early Diagnosis; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000706:statistics & numerical data*; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000097:blood*; D009426:Netherlands / Q000453:epidemiology; D009929:Organ Size; D011237:Predictive Value of Tests; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000453:epidemiology / Q000473:pathology; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012680:Sensitivity and Specificity; D013997:Time Factors
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D017430:Prostate-Specific Antigen